Skip to main content
Contact Us
Subscribe
E-Edition
49°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Volitionrx Ltd
(NY:
VNRX
)
0.8390
+0.0280 (+3.45%)
Streaming Delayed Price
Updated: 12:13 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Volitionrx Ltd
< Previous
1
2
3
Next >
Stocks That Hit 52-Week Lows On Tuesday
September 27, 2022
On Tuesday, 456 stocks hit new 52-week lows.
Via
Benzinga
Sidoti's August Micro-Cap Virtual Conference
August 16, 2022
Via
ACCESSWIRE
Around $1.1 Million Bet On Ring Energy? Check Out These 3 Penny Stocks Insiders Are Buying
August 05, 2022
U.S. crude oil futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Earnings Scheduled For May 11, 2022
May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Xenetic Biosciences, Inc. and VolitionRx Limited Collaborate to Develop NETs-Targeted Adoptive Cell Therapies for the Treatment of Cancer
August 02, 2022
Via
ACCESSWIRE
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
August 01, 2022
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings...
Via
Benzinga
Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday's Mid-Day Session
July 29, 2022
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders.
Via
Benzinga
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update
July 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why Amazon Is Trading Higher By 12%: Here Are 23 Stocks Moving Premarket
July 29, 2022
Gainers Getty Images Holdings, Inc. (NYSE: GETY) rose 104.5% to $21.47 in pre-market trading.
Via
Benzinga
Looking Into VolitionRX's Return On Capital Employed
June 16, 2022
According to data from Benzinga Pro, during Q1, VolitionRX's (AMEX:VNRX) reported sales totaled $114.21 thousand. Despite a 4.81% increase in earnings, the company posted a loss of $7.72 million.
Via
Benzinga
Recap: VolitionRX Q1 Earnings
May 11, 2022
VolitionRX (AMEX:VNRX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings VolitionRX missed estimated earnings...
Via
Benzinga
A Preview Of VolitionRX's Earnings
May 10, 2022
VolitionRX (AMEX:VNRX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that VolitionRX will...
Via
Benzinga
VolitionRX Earnings Perspective: Return On Capital Employed
March 31, 2022
Benzinga Pro data, VolitionRX (AMEX:VNRX) reported Q4 sales of $14.24 thousand. Earnings fell to a loss of $8.11 million, resulting in a 12.9% decrease from last quarter.
Via
Benzinga
Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday
December 14, 2021
Photo by Chris Montgomery on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
Sidoti December Micro Cap Virtual Conference
December 07, 2021
Presentation Times Released for 75+ Presenting Companies Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / December 7, 2021 / Sidoti & Company, LLC has released the presentation...
From
Sidoti & Company, LLC
Via
AccessWire
Sidoti Microcap Virtual Conference
November 05, 2021
A Conference Open to All Classes of Investors 70+ Companies Presenting and Meeting Interested Investors 1x1 Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / November 5, 2021 /...
From
Sidoti & Company, LLC
Via
AccessWire
VolitionRx Ltd. (NYSE American: VNRX) Featured in Coverage of Benzinga’s Healthcare Small Cap Conference
September 24, 2021
Via
Investor Brand Network
VolitionRX Earnings Perspective: Return On Capital Employed
September 24, 2021
According to Benzinga Pro data, during Q2, VolitionRX (AMEX:VNRX) posted sales of $24.78 thousand. Earnings were up 3.03%, but VolitionRX still reported an overall loss of $5.90...
Via
Benzinga
Sidoti Microcap Virtual Conference
August 18, 2021
Presentation Times Released for 50 Presenting Companies Wednesday and Thursday, August 18-19, 2021 NEW YORK, NY / ACCESSWIRE / August 18, 2021 / Sidoti & Company, LLC has released the presentation...
From
Sidoti & Company, LLC
Via
AccessWire
VolitionRX Ltd (VNRX) Q2 2021 Earnings Call Transcript
August 12, 2021
VNRX earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
August 16, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be...
From
Stock News Now
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For August 11, 2021
August 11, 2021
Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter. • Gamida Cell (NASDAQ:GMDA) is...
Via
Benzinga
Looking Into VolitionRX's Return On Capital Employed
June 18, 2021
In Q1, VolitionRX (AMEX:VNRX) posted sales of $25.53 thousand. Earnings were up 7.53%, but VolitionRX still reported an overall loss of $6.09 million. In Q4, VolitionRX brought in...
Via
Benzinga
Looking Into VolitionRX's Return On Capital Employed
June 04, 2021
During Q1, VolitionRX's (AMEX:VNRX) reported sales totaled $25.53 thousand. Despite a 7.53% in earnings, the company posted a loss of $6.09 million. VolitionRX collected $7.12...
Via
Benzinga
Sidoti Summer Virtual Small-Cap Conference
June 22, 2021
Presentation Times and Weblinks Released for Approximately 70 Presenting Companies Wednesday and Thursday, June 23-24, 2021 NEW YORK, NY / ACCESSWIRE / June 22, 2021 / Sidoti & Company, LLC has...
From
Sidoti & Company, LLC
Via
AccessWire
Volition Rx Limited (VNRX) Q1 2021 Earnings Call Transcript
May 12, 2021
VNRX earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Sidoti Microcap Virtual Conference
May 18, 2021
May 19 - 20, 2021 Presentation times and weblinks released for over 60 presenting companies NEW YORK, NY / ACCESSWIRE / May 18, 2021 / Sidoti & Company, LLC has released the presentation schedule and...
From
Sidoti & Company, LLC
Via
AccessWire
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.